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Excision of the bacterial group II intron RmInt1 has been
demonstrated in vivo, resulting in the formation of both intron
lariat and putative intron RNA circles. We show here that the
bulged adenosine in domain VI of RmInt1 is required for splic-
ing via the branching pathway, but branch sitemutants produce
small numbers of RNAmolecules in which the first G residue of
the intron is linked to the last C residue. Mutations in the coor-
dination loop in domain I reduced splicing efficiency, but
branched templates clearly predominated among splicing prod-
ucts. We also found that a single substitution at the EBS3 posi-
tion (G329C), preventing EBS3-IBS3 pairing, resulted in the
production of 50 to 100 timesmore RNAmolecules inwhich the
5 and 3 extremities were joined. We provide evidence that
these intron molecules may correspond to both, intron circles
linked by a 2-5 phosphodiester bond, and tandem, head-to-tail
intron copies.
Group II introns are large catalytic RNAs with a conserved
secondary structure consisting of six domains arranged around
a central wheel (1). Group II introns may self-splice via several
different pathways (Fig. 1). Themain splicing pathway in group
II introns involves two sequential trans-esterification reactions.
In the first, the 2-hydroxyl of a bulged adenosine near the end
of the intron, in domainVI, triggers a nucleophilic attack on the
5 splice site. In the second reaction, the 2–5 branched prod-
uct is released as a lariat when the free 3-OH at the end of the
5 exon attacks the 3 splice junction joining the two exons
(2–5). In ai5, a yeastmitochondrial group IIB intron, the func-
tional group II intron branch site consists of the bulged adeno-
sine, the wobble pairs (G-U) flanking this residue and, possibly,
the purine-enriched sequence in domain VI on the strand
opposite the bulged nucleotide (6–8). Recent studies have
reported the presence, within domain I of group IIB introns, of
a branch site receptor known as a coordination loop (9), which
is required for trans-esterification (8), but these findings have
been called into question (10). This coordination loop has been
identified as a key element for exon ligation, as it positions the
exon and intron binding sequences, the EBS3-IBS3 base pair
and the EBS1-IBS1 helix, in an appropriate conformation for
reaction (9). There is also an alternative splicing pathway, the
first step of which involves hydrolysis. The ligated exons and
linear intron are then generated in a standard second step (11–
13). An additional excision reaction, in which the intron is
excised as a putative circle, has also been proposed for some
group II introns (14–16). In this case, prior release of the 3
exon from the precursor molecules, presumably via a trans-
splicing mechanism, seems to be required for the generation of
a putative 2-5 ligated circular intron. The origin and function
of such intron circles in vivo remains unknown.
RmInt1 is a mobile subclass IIB3 intron (17). It has also been
assigned to phylogenetic bacterial classD (17, 18) on the basis of
the internally encoded (ORFwithinDIV) reverse transcriptase-
maturase (intron-encoded protein (IEP)). This group II intron
is excised, both in vivo and in vitro, as an intron lariat (16, 19).
No hydrolytic pathway has yet been described in vivo for
RmInt1, but the excision of this intron in a linear form has been
demonstrated in vitro (19). We have also reported that the
RmInt1 group II intron is also excised as putative intron circles
in vivo (16).
In this study, we assessed the relevance of the branch point
adenosine and the coordination loop, including 3 exon binding
site (EBS3),5 for in vivo excision of the bacterial group II intron
RmInt1 and analyzed the production of intron forms in which
the 5 and 3 extremities of the intron are joined together by a
covalent bond. Our findings provide new insights into the pos-
sible origin of excised circular intron molecules.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Media, and Growth Conditions—Sinorhi-
zobium meliloti RMO17 was used to characterize the in vivo
activities of RmInt1 because this rhizobial strain has no copy of
RmInt1 in its genome (20). Escherichia coliDH5 was used for
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the construction of mutants and cloning. S. meliloti was cul-
tured in TY medium at 28 °C, whereas E. coli strains were
grown in LB medium at 37 °C. For plasmid maintenance, we
added the following antibiotics as required: 200g/ml kanamy-
cin for rhizobia and 50 g/ml kanamycin for E. coli; 200 g/ml
ampicilin and 10 g/ml tetracycline, for both types of bacteria.
RmInt1 and Mutant Derivatives—pKGEMA4T7 is a con-
struct similar to pKGEMA4 (20), containing an RmInt1-ORF
intronwith short flanking exons20/5 and the IEP expressed
from a position upstream from the 5 exon, but with a phage
T7 promoter inserted into the XhoI site engineered in domain
IV of the ribozyme. pKG4dVT7 is a mutant derivative of
pKGEMA4T7 in which the catalytic triad GTT is replaced by
CGA in domain V of the RmInt1 ribozyme. The dVI-A764,
dVI-A764C, dVI-pU, EBS3C, EBS3U, EBS3A, and CL2 point
mutants were generated by site-directed mutagenesis with the
Altered Sites II in Vitro Mutagenesis pAlter-1 System (Pro-
mega), with the changes introduced into pALORFT7.We gen-
erated pALORFT7 by inserting the SacI fragment containing
ORFT7 from pKGEMA4T7 into pAlter-1. The oligonucleo-
tides used for mutagenesis are listed in supplemental Table 1.
The final constructs were generated by replacing the ORF in
pKGEMA4 with a ORFT7-containing fragment generated by
SacI digestion of the mutated pALORFT7 plasmids.
pKG4CL1T7 was constructed by two-step PCR (16), with the
Triple MasterTM PCR system (Eppendorf). Two pairs of prim-
ers were designed for amplification of the 5 and 3 sections of
the ribozyme: the SacBbr and CL/DN primers were used to
generate the 270-bp upstream fragment; the 435-bp down-
stream fragment was generated by amplification with the
CL/UP and pT7R primers. The mutagenic primers contained
an overlapping region of 27 bp and introduced the AGCCC
sequence in place of GAGGA at ribozyme positions 222–226.
The second PCR step was performed with SacBbr and pT7R
primers and generated a 678-bp fragment. The PmlI/XhoI-di-
gested PCR product was inserted in place of the wild-type frag-
ment in pKGEMA4T7. The double mutant was obtained with
the same protocol as for pKG4CL2T7, but with pALORF-
CL1T7 used as the template for mutagenesis.
All six -mutants were obtained by PCR with the Accup-
rimeTM PCR System (Invitrogen). G was generated by one
round of PCR with the 5Q_CAT and G primers. The C
mutantwas generated by a two-step PCR inwhich the 5Q_CAT
and C-rv primers were used to amplify the 5 region of the
ribozyme and the 3 region was obtained by amplification with
the C-fw and 6QR_LACZ primers. In the second round of
PCR, a mixture of these two PCR products was subjected to
amplification with the 5Q_CAT and 6QR_LACZ primers. The
exchanged C-G mutant was generated by two-step PCR
with the 5Q_CAT and C-rv primers (5 region) and the C-fw
and G primers (3 region). The next round of PCR was per-
formed with the 5Q_CAT and G primers. The EBS3C
C-G combined mutant was obtained by using an EBS3C
mutant ribozyme as the PCR template. All of the mutated
ribozymes were then inserted, as PmlI-BlnI fragments, into
pICGter-E1E2, which consists of short flanking exons (20/
5, exon 1 and exon 2, respectively) fused in-frame with the N
terminus of the lacZ gene under the control of a constitutive
promoter and capped with a custom-designed Rho-indepen-
dent transcription terminator (21).Mutants derived frompICG
required IEP trans-complementation, so we produced this pro-
tein constitutively from pKGIEP (22).
RNA Isolation—RNA was extracted from cultures of free-
living S. meliloti strain RMO17 containing plasmids carrying
the wild-type or mutant RmInt1, as described previously (16).
The bacterial cells present in 10 ml of a culture with an A600 of
0.6 units were lysed in the presence of proteinase K (in 1.4%
SDS, 4 mM EDTA, 125 g proteinase K) for 10 min at 65 °C.
DNAwas eliminated by incubation with 50 units of RNase-free
DNase I (Qiagen) and subsequent phenol (pH 4.5)/chloroform/
isoamylalcohol extraction. Finally, the RNA was precipitated
and resuspended in 25 l of nuclease-free water.
Weminimized the amount of DNA present in the RNA sam-
ples by using the RNeasyMini Kit (Qiagen). RNeasy technology
FIGURE 1.Pathways of group II intron splicing. Linearmolecules are shown as solid unbranched lines, lariatmolecules are shown as branched lines, and intron
circles are shown as circles. Exon sequences are shown as white (5 exon) or black (3 exon) boxes. The mechanisms of the different splicing pathways are
described in the text.
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makes it possible to purify high quality RNA rapidly, due to the
combination of the stringency of guanidine-isothiocyanate lysis
and the efficiency of silica-membrane purification. RNA was
isolated according to the manufacturer’s instructions. Biologi-
cal samples were lysed and homogenized. Ethanol was added,
and the lysate was loaded onto the RNeasy silica membrane,
which efficiently binds RNA, making it possible to wash off all
the other contaminants. High quality RNA was eluted in 30 l
of water. This technology efficiently removes most of the DNA
without the need for DNase treatment, but certain applications
are sensitive to very small amounts of DNA. We therefore
removed any residual trace amounts of DNA by RNase-free
DNase I digestion (Qiagen) followed by subsequent silica-
membrane purification and elution in 30 l of nuclease-free
water. The absence of DNA was verified by PCR.
Primer Extension Assay—Primer extension reactions were
performed as described previously (16). We annealed 15 g of
total RNA with 0.2 pmol (300,000 cpm) of (5-32P)-labeled P
primer in 10 mM PIPES (pH 7.5), 400 mM NaCl. This mixture
was heated at 85 °C for 5 min, rapidly cooled to 60 °C, and then
allowed to cool slowly to 45 °C, over a period of 10 min. Exten-
sion reactions were carried out by reverse transcription with
AMV reverse transcriptase (Roche Applied Science) at 42 °C
for 60min. Samples were resolved by electrophoresis in a dena-
turing 6% polyacrylamide gel and quantified with the Quantity
One software package (Bio-Rad). The excision efficiency was
normalized to the WT levels and calculated according to the
intensity of the 97-nt product to compare the results between
the different plasmid construct used along the experiment.
RT-PCR—RT-PCR was performed as described previously
(16). First-strand cDNA synthesis was initiated by annealing 6.5
g of total cellular RNA and 25 pmol of a specific primer in the
presence of 12.5 mmol dNTPs. We used Ect1 or ICI oligonu-
cleotides for cDNA synthesis. We then added 5 first strand
buffer, 0.2 mol DTT, 30 units of RNAguardTM RNase inhibitor
(GE Healthcare), and 400 units of SuperScript II RNase H
reverse transcriptase (Invitrogen), and the reaction mixture
was incubated at 42 °C for 120 min. We used one-fifteenth of
the products of this reaction as a template for PCRwith 15 pmol
of LL primer, which was designed to be complementary to a
sequence 59 nt from the 3 end of RmInt1, 15 pmol of 5-radio-
labeled P primer (150,000 cpm), 6.25mmol dNTPmix, 50mM
HEPES (pH 7.9), 1.5 mM MgCl2, 50 mM KCl, and 1 unit of Taq
polymerase in a final volume of 25l. The RT-PCR products (1
l) were resolved by electrophoresis in a denaturing 6% poly-
crylamide gel.
The bands subsequentlywere analyzed by sequencing at least
eight different clones. Before sequencing, cloned PCR products
derived from templates in which the intron extremities were
linked together were selected by PCR with the Iq3 and P
primers.
Quantitative Real-time RT-PCR—We generated the first-
strand cDNA from 10 g of S. meliloti RMO17 total RNA car-
rying various plasmids, with 12.5 pmol of ICI oligonucleotide
used as the primer and 300 units of Superscript II reverse tran-
scriptase RNaseH (Invitrogen), in a final volume of 10l (16).
We carried out qPCR in the iCycler iQ system (Bio-Rad). We
used a 1:10 dilution of the cDNA product, with the addition of
0.2 mM of each specific oligonucleotide primer, SYBR Green I
(dilution of 1:10,000) and 0.5 units of PlatinumTaq polymerase
(Invitrogen), according to themanufacturer’s instructions. The
following real-time PCR cycling conditions were used for all
quantifications: 3 min at 95 °C, followed by 40 cycles of 15 s at
95 °C, 30 s at 68 °C, and 15 s at 72 °C and a final extension phase
for 3min at 72 °C. The templates in which the 5 and 3 extrem-
ities of the intron were joined together were amplified with the
Ect1 and Iq3 primers. Iq3 contains the last six nucleotides of
the RmInt1 ribozyme, resulting in the amplification principally
of the abovemolecules, with branched (lariat)molecules ampli-
fied much less efficiently (additional information in supple-
mental Fig. 1). Standard dilutions of known quantities of plas-
mid DNA were included in each run for the generation of
quantification curves and the evaluation of amplification effi-
ciency. RNA samples that had not been treated with reverse
transcriptase were included to check for DNA contamination.
Negative controls in which the template was omitted were also
included. In some experiments, amplification was also carried
out with the 5Q_CAT and P primers, demonstrating the pres-
ence of similar precursor levels in each RNA sample (data not
shown). Template amplification was assayed in duplicate in
each PCR run, for at least three RNA preparations. A melting
curve analysis was performed in all PCR runs to check that
there were no primer dimers (data not shown).
RESULTS
Branch Site, Coordination Loop, and EBS3 Mutants—We
evaluated the role of the predicted coordination loop, including
the EBS3, and the branch site adenosine (Fig. 2A), in RmInt1
excision reaction in vivo, by constructing a series of mutants in
pKGEMA4T7. This plasmid contains an RmInt1-ORF intron
and short flanking exons 20/5, with a phage T7 promoter
inserted in domain IV and the IEP expressed from a position
upstream from the 5 exon. Three mutations were introduced
into the branch site: deletion of the adenosine (A764), its
replacement by a C residue, and the pairing of this residue with
a uridine residue inserted on the other strand of DVI (Fig. 2B),
hereafter referred to as A, A764C, and pU, respectively. We
also introduced mutations into the coordination loop: one
mutation affecting either side of the loop sequence and a third
mutation affecting both sides (Fig. 2C), equivalent to the coor-
dination loop mutants generated for in vitro studies in ai5 (8).
The 5 side loop mutation (CL1) includes nucleotides 222–226
and results in the replacement of a GAGGA sequence with
AGCCC. This mutation prevents base pairing between the two
sides of the loop. The mutation on the 3 side of the loop
sequence (CL2) involved the replacement of the A in position
330 with a C residue. A combined mutant (CL3) in which both
sides of the loopwere affectedwas also generated. Finally, G329
(EBS3) was replaced separately with C, U, and A residues, pre-
venting EBS3-IBS3 base pairing. None of these mutations
altered the identity of nucleotide  (C227) that presumably
form a canonical pair with nucleotide  (G266), immediately 5
of EBS1, interaction that facilitate base pairing between the 5
exon and the intron (23).
Effects ofMutation in RmInt1 Excision Reaction in Vivo—We
assessed the efficiency of the intron excision reaction by carry-
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ing out primer extension analyses with an oligonucleotide
sequence (see supplemental Table 1) complementary to a
sequence located 80–97 nt from the 5 end of the intron (Fig.
3A). Assays with total RNA from S. meliloti RMO17 expressing
the RmInt1 intron from pKGEMA4T7 showed a major, strong
97-nt extension product corresponding to excised intron RNA
(Fig. 3A, lane 8). This 97-nt band was not detected with RNA
from cells harboring pKG4dVT7 (Fig. 3A, lane 9), in which
the ribozyme carries mutations affecting the critical con-
served AGC-GUU pairing of the intron RNA domain V
(GUU3CGA). Similarly, all of the branch site point mutations
(Fig. 3A, lanes 1–3) resulted in a lack of detectable excision,
even after long periods of exposure, suggesting an inability of
the intron to branch efficiently and to form a lariat. These
branch site substitutions are known to prevent branching and
lead to the relatively inefficient production of linear intronmol-
ecules in other introns (6). Nonetheless, no linear intron RNA
was detected in RmInt1 branch site mutants by primer exten-
sion, 5-RNA ligase-mediated rapid amplification of cDNA 5
ends (RLM-RACE) or cRT-PCR. By contrast to branch point
mutants, some of the putative branch site receptor mutants
gave a band corresponding to the excision product. The CL2
mutant, in which the 3 side of the loop was affected, displayed
8% wild-type splicing activity (Fig. 3A, lane 5), whereas the
5-loopmutant CL1 (Fig. 3A, lane 4) displayed a stronger splic-
ing defect (4%wild-type). The band generated on intron exci-
sion was not detected in the combined mutant, CL3 (Fig. 3A,
lane 6). These results are consistent with those reported for
similar mutations in the coordination loop of ai5 in vitro (8).
However, we cannot rule out the possibility that the branch site
receptor mutations have effects on the structure of the
ribozyme leading to the splicing defect observed in vivo for
RmInt1, rather than specifically affecting the branching
reaction.
The EBS3-IBS3 interaction stabilizes and aligns the 3 exon
during the second step of splicing. Substitutions affecting EBS3,
the binding site for the 3 exon, have been shown to have min-
imal effects on the structure of the loop but strongly inhibit the
second step of the splicing reaction (23). On the other hand, it
has been suggested that the branch site and the 3 exon bind the
coordination loop independently (8). The EBS3C, U, and A
mutations (Fig. 3A, lane 7 and data not shown) resulted in sig-
nificantly lower levels of excision product (30–40% wild-
type), which nonetheless remained higher than those for the
other loop mutants. According to previous observations, our
results would involve a different type of impairment of lariat
formation in the EBS3mutant. Although the CLmutants could
derivate from structural destabilization that reduces the effi-
ciency of the first step of the splicing reaction, the EBS3
mutants presumably display inhibition of the second step.
Branching reaction is highly reversible (24, 25), which requires
that the second step of splicing serve as a kinetic trap (25). Thus,
the impairment in the second step of splicing in the EBS3
mutant could contribute to the reversibility in the first step
giving rise to a reduction of excision product detected by
primer extension.
FIGURE 2.Mutagenic approach to investigation of the RmInt1 excision mechanism. A, schematic secondary structure of the RmInt1 ribozyme is repre-
sented as a solid line, with tertiary contacts indicated by dashed lines and Greek letters; solid gray arrows show the 5 and 3 splice sites, and the circled A
represents the branch point adenosine in domain VI. The Gposition, located in the J2/3 region, and EBS3G are highlighted. B, diagramof domain VI, showing
the set of mutants analyzed: branch point deletion (A), bulged A-to-C transversion (A764C), adenosine pairing (pU), and intron last nucleotide C-to-G
transversion (G). C, schematic diagram of the coordination loop; tertiary interactions are shown surrounded by shaded boxes. The mutants are identified as
follows: 5 loop mutant (CL1), 3 side single mutant (CL2), and the combined mutant (CL3) containing both mutations. EBS3 mutants are also shown.
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Detection of RmInt1 Products in Vivo by Reverse Transcrip-
tion and PCR—In a previous work, we demonstrated, by RT-
PCR, the existence in vivo of RmInt1 RNAmolecules compati-
ble with circular intron forms in which the first G residue of the
intron is linked to its last C residue (16). RT-PCR assays (Fig.
3B) were carried out to determine the ability of the mutants to
generate these intron forms. Two major RT-PCR products of
156 and 150 nt were observed in cells expressing the wild-type
intron from pKGEMA4T7 (Fig. 3B, lane 16), but not in cells
expressing the splicing-defective mutant pKG4dVT7 (Fig. 3B,
lane 18). The more slowly migrating 156-nt band corresponds
to the amplification of templates in which the 5and 3 extrem-
ities of the intron are joined together, whereas the 150-nt RT-
PCR product is derived from a substrate consisting of an intron
lariat in which the branch point is the bulged adenosine in
domain VI (16). The intron lariat and putative intron circles
molecules seem to have different hydrodynamic properties that
may be influenced by both the type of folding of the different
excised intron molecules and a distinctive interaction of these
forms with the IEP (16). Although the degradation rate of both
intron molecules is currently unknown, we observed that the
amount of putative circles decreased when cells were collected
at stationary phase, whereas the levels of lariat were unchanged
or slightly raised (data not shown). For this reason, our experi-
ments were carried out at early logarithmic phase. Thus, the
conclusions in the current work rest on the assumption that
degradation rates are unchanged.
RT-PCR analysis revealed the presence of the larger RT-PCR
product in the three branch-site mutants (Fig. 3B, lanes 2, 4,
and 6), whereas the product derived from the lariat was barely
detectable only in the A764C mutant (lane 4), consistent with
the low efficiency of cytosine as the branch point nucleotide
demonstrated both in vitro and in vivo in other introns (6, 26,
27). The larger RT-PCR products of A, A764C, and pU
mutants were cloned and sequenced. All the clones displayed
the expected linkage between the first and last residue of the
intron. Therefore, we conclude that the production of RNA
molecules with joined 5 and 3 intron ends is independent of
the branching reaction.
By contrast to what was observed for the branch-site muta-
tions, RT-PCR assays showed the product of the lariat to be
present in all coordination loop mutants (Fig. 3B, lanes 8, 10,
and 12) at different levels, consistent with the amount of prod-
uct detected on primer extension analysis. In addition, the
product derived from RNA molecules with joined intron
extremities was detectable only in the CL2 mutant, suggesting
that these intron speciesmay be produced inefficiently by these
mutants.
PCR and RT-PCR assays revealed the presence of both DNA
(Fig. 3B, lane 13) and RNA (Fig. 3B, lane 14) templates with
linked 5 and 3 intron extremities in the EBS3C mutant,
whereas the product derived from the intron lariat is no longer
detectable. All cloned 156 nt RT-PCR products displayed the
expected linkage between the first G residue of the intron and
its last C residue. These results are particularly striking because
the extension product (Fig. 3A, lane 7) is thought to be mostly
derived from intron lariat molecules. We have shown previ-
ously that primer extension assays using RNA and RNP parti-
cles from S. meliloti cells expressing the wild-type intron
revealed two extension products that differ by one nucleotide
(97–98 nt) relative to the position expected for the 5 end of the
intron, with the shorter product as themajor one (16). Interest-
ingly, primer extension performed on a circular intron has been
reported to result in two extension products that differ by one
nucleotide, with the longer product as the major one (14). Fur-
thermore, reverse transcriptase is known to pause after reading
through the 2–5 linkage in a nonlariat RNA (28), whereaswith
lariat RNA, the pause occurs before reading through the 2–5
FIGURE 3. Effect of branch site, coordination loop, and EBS3 mutations on the splicing reaction in vivo. A, proteinase K-treated total RNA from the
S. meliloti RMO17 strain harboring the wild-type intron pKGEMA4T7, the splicing-defective mutant pKG4dVT7, and the corresponding mutants was reverse
transcribedwith an intron-specific primer (P). The splicing defect ofmutants EBS3U andAwas similar to that of the EBS3Cmutant (not shown). The 97-nt cDNA
products obtained from excised intron RNA are indicated, together with the more slowly migrating bands corresponding to unspliced precursor derived
transcripts (110 and 124 nt), which appear to be processed at specific 5U residues as indicated by RACE mapping. B, the products of RmInt1 in vivo were
detected by reverse transcription and PCR. Reactionswere carried out with () andwithout () prior RT of RNA from S. meliloti RMO17 harboring pKGEMA4T7,
pKG4dVT7, anddomain I andbranch-sitemutations. The sizes of the identified products are indicated in bp; a schematic representation of the PCRproducts for
the intron lariat, head-to-tail intron dimers, and intron circles is also shown, in which the circled A corresponds to the bulged adenosine in domain VI.
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linkage (14). Thus, one possible interpretation of our data is
that the extension product observed in the EBS3C mutant
could be mostly the larger 98-nt product and that the mutant
intron might excised in vivo as putative intron circles.
Quantification of Intron Species with Linked 5 and 3 Ends—
We further investigated the effect of branch site, coordination
loop, and EBS3 mutations in the production of RNAmolecules
with linked 5 and 3 intron ends, by carrying out quantitative
real-time RT-PCR with the Ect1 and Iq3 primers (Fig. 4A), on
a cDNA template synthesized by the reverse transcription of
total RNA with the intron-specific ICI primer. As the 3 end of
the Iq3 primer is complementary to the last six nucleotides
of the intron (tail of the lariat molecule), this amplification gener-
ates a 207-bp product from intron RNA templates with linked
ends (circular introns or tandem, head-to-tail intron copies)
but not from a lariat template (see also supplemental Fig. 1).
Our results indicate that 50–100 times more intron RNAmol-
ecules with linked intron 5 and 3 ends are produced by the
EBS3Cmutant than by the wild-type intron, whereas the num-
ber of suchmolecules are an order ofmagnitude lower and close
to background levels (dV mutant) for branching and coordina-
tion loop mutants (Fig. 4B). Consistent with the results of RT-
PCR assays, qPCR in the absence of reverse transcription gen-
erated only one-third to one-half as many DNA templates with
linked intron extremities as qPCR of equivalent RNA templates
in the EBS3C mutant (see supplemental Fig. 2). These results
clearly indicate that the replacement with a C residue of EBS3G
boosts the production of products compatible with a circular
template, or tandem intron copies, whereas branch site and
coordination loopmutations behave differently, decreasing the
production of these intron species.
Nature of Intron Forms in EBS3 Mutants—Our results dem-
onstrate that the replacement of the nucleotide in intron posi-
tion EBS3G by a C residue increases the abundance of intron
products in which the first G residue of the intron is linked to
the last C residue. We therefore investigated whether the phe-
notypes associated with EBS3 substitution were nucleotide-
specific. In contrast to the EBS3Cmutation, the RT-PCR prod-
uct derived from lariat intron is clearly detected in both the
EBS3U and EBS3A mutants (Fig. 5A, lanes 8 and 10), which
suggests a lower abundance of intron RNA molecules with
linked 5 and 3 ends. That this was the case was confirmed by
qPCR assays (Fig. 5B), which show that these intron species are
increased by 100-fold in the EBS3C mutant, but by 25- and
37-fold in the EBS3U and EBS3A mutants, respectively. As
expected for a Watson-Crick pair, when the EBS3-IBS3 base
pairing was reestablished by compensatory mutations at IBS3,
the production of these intron forms showed a significant
reduction. Thus, one possible interpretation of our data were
that in addition to putative intron circles, for the EBS3C
mutant, these intron products may result from EBS3 (C) being
complementary to the first intron nucleotide (G), making it
possible for the intron to undergo reverse splicing at the junc-
tion with the 5 exon, resulting in the production of tandem
head-to-tail intron copies. We tested this hypothesis, by isolat-
ing and analyzing the intron constructs harbored by the EBS3C
mutant. Plasmids from four of 13 colonies analyzed showed a
restriction profile compatible with head-to-tail intron copies
(Fig. 5C), which was further confirmed by DNA sequencing.
These findings indicate that the EBS3C mutant is able to
reverse splice efficiently into the intron-insertion site in the 5
exon (DNA target), resulting in the formation of stable tandem
intron copies potentially generatingDNAandRNA intronmol-
ecules with linked 5 and 3 ends, intron species that would not
be detected by primer extension, but would be detected in RT-
PCR assays. Another evidence that supports the existence of
head-to-tail intron DNA molecules is that the PCR product
obtained in the absence of reverse transcription is no longer
detectable by using RNA isolation methods (see “Experimental
Procedures”) that efficiently eliminated most of the DNA from
the RNA samples (Fig. 5A, lane 5 and compare with Fig. 3B,
lane 13).
We investigated whether the EBS3C mutation also
allowed the intron to attack the 5 splice site (RNA target)
FIGURE 4. Quantitative real-time RT-PCR data analysis of RmInt1 prod-
ucts inwhich the 5 and 3 extremities are linked. A, schematic diagram of
the expected PCR products. cDNA was synthesized from S. meliloti RMO17
total RNA carrying various plasmid constructs, with the ICI oligonucleotide
primer. qPCR was performed in the iCycler iQ system (Bio-Rad), with the Ect1
and Iq3primers and SYBRGreen I. Amplification generates a 207-bp product
from intron RNA templates with linked extremities, whether in the form of
circular introns or tandem, head-to-tail intron copies, but not from a lariat
template. B, amplification levels of the 207-bp product for WT, coordination
loop, EBS3, branch site, and domain V mutants. The graph shows the thresh-
old cycle (Ct) for the indicated constructs. The Ct is the point at which the
fluorescence intensity of the reaction first exceeds the background level. The
data shown are means S.E. of at least two replicates in 96-well plates and
three independent reactions, each with a different RNA preparation. Three
main groups can be distinguished: the WT group, Ct 25 (2.7 10
4 cDNA
copies/50 ng total RNA); the putative branch site-docking group, Ct 28.36
(103 cDNA copies/50 ng total RNA), which includes splicing-defective
domain I and domain VI mutants, with levels close to the background level
displayed by the domain V mutant (Ct  29); and the EBS3 group, Ct  19
(2.6 106 cDNA copies/50 ng total RNA). (qPCR parameters: E	 92% and
R2 	 0.991). DNA standard curves were generated for quantification, and
melting curve analysiswas carriedout in all PCR runs, to check that therewere
no primer dimers (not shown). RNA samples not treated with reverse tran-
scriptase and negative controls containing no template were included to
monitor the reactions (not shown).
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efficiently, by introducing this mutation into a construct car-
rying nucleotide substitutions in the IEP (YAHH mutant)
that abolish reverse transcriptase activity and thus intron
mobility (22). RT-PCR assays and DNA sequencing revealed
that this combined mutant had a phenotype similar to the
single mutant EBS3C, with a greater abundance of the 156-nt
product with the expected 5 and 3 intron junction (Fig.
5D), which was further confirmed by qPCR (data not shown).
We therefore conclude that the replacement of EBS3 with a
C nucleotide leads the intron to attack both the DNA and
RNA sites efficiently, resulting in the production of stable
(DNA) or transient (RNA) tandem head-to-tail intron cop-
ies, respectively.
Involvement of - Pairing in Intron Forms with Linked 5
and 3 Ends—It has been suggested that free 5 exon attacks the
3 splice site in intron circle formation, thereby releasing the
downstream intron terminus while splicing to the 3 exon. In
addition to EBS3, base pairing (-) between the last nucleo-
tide () of the intron and the  nucleotide, which is located in
the J2/3 segment connecting domains II and III, is required for
an efficient second splicing step (29, 30). Toor et al. (31)
recently showed that the  nucleotide was located near the
domain V bulge, positioning the 3 splice site for catalysis. We
investigated the nature of intron species with linked 5 and 3
intron ends, by first checking the effect of  and mutations in
the production of these intron forms. The RmInt1 ORF-in-
FIGURE 5. Effect of the different EBS3 substitutions on the splicing reaction in vivo. A, RT-PCR was performed with () and without () prior RT of
RNA from S. meliloti RMO17 harboring intron constructs bearing various EBS3 substitutions and a wild-type IEP: the EBS3G (WT) was replaced with C, U,
and A residues. B, RT-qPCR analysis of RmInt1 molecules with linked 5 and 3 ends is shown in different EBS3-IBS3 combined mutants. The EBS3G (WT)
was replaced with U, C, and A nucleotides as well as the compensatory mutations were introduced into the IBS3 position to restore the interaction. The
threshold cycles were plotted as the mean S.E. The background level is displayed by the splicing-defective mutant dV. The different EBS3 mutations
exhibit a differential increase in the amount of 5-3-linked intron extremities molecules, being the EBSC mutant which highly swells these levels. The
rate of thesemolecules is reduced when a compensatory change in the IBS3 is introduced. C, the EBS3Cmutant can generate intron dimers. Head-to-tail
intron copies were found when 13 colonies from an EBS3Cmutant were analyzed. The EcoRI/XhoI digestions of three clones representative of the three
profiles observed are shown: clones with only one copy of theORF intron (M, monomer), others formed from ribozyme dimers (D), and others that may
correspond to intron oligomers (O). Schematic diagrams of the various constructs are drawn to scale at the top. PKm, the promoter of the Km resistance
gene, is represented as a black arrow; the gray box corresponds to the IEP; white boxes represent the ribozyme; E, EcoRI; and X, XhoI restriction sites.
D, total RNA from S. meliloti RMO17 harboring intron constructs with the EBS3G (WT) or the EBS3C substitution and a RT-deficient IEP mutant (YAHH)
were assayed by RT-PCR.
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tron and mutant derivatives were analyzed with pICG con-
structs carrying a Rho-independent transcription terminator
complemented with the IEP expressed in trans (21).
Twomutations were introduced to prevent tertiaryWatson-
Crick - pairing (Fig. 2A and B): replacement of the  nucle-
otide G452 with a C residue in the J2/3 region (hereafter
referred to as the Cmutant) and replacement of the  nucle-
otide C1884 with a G residue (hereafter referred to as the G
mutant). A third mutant was also constructed to restore -
pairing, but with a C452-G1884 combination. In addition, the
EBS3C mutation was introduced into each of these three
mutants. As for pKGEMA4T7 constructs, the EBS3C mutation
in pICG significantly decreased intron excision (49%wild-type,
Fig. 6A) and RT-PCR assays showed the production of larger
amounts of the 156-nt product (Fig. 6B, lane 6).
The Cmutation was associated with 34% wild-type splicing
activity (Fig. 6A, lane 4), probably due to blockage of the second
step of splicing. As expected, the EBS3CC double mutant
(Fig. 6A, lane 5) displayed a stronger splicing defect (15% wild-
type) and produced larger amounts of the 156-nt RT-PCR
product (Fig. 6B, lane 10). Surprisingly, the G mutation had
no significant effect on intron splicing activity (95% wild-type,
Fig. 6A, lane 6), and themain signal obtained in RT-PCR assays
corresponded to the lariat-derived product (Fig. 6B, lane 12).
One possible explanation for these findings is that, unlike the
C mutation, the wild-type G452 residue in the G mutant
may establish a compatible interaction that restores equivalent
- pairing at cryptic 3 splice sites (30). Note that the RmInt1
3 splice site is located in the midst of a run of three C residues.
As expected, the EBS3CG double mutant displayed a
strong splicing defect (24% wild-type, Fig. 6A, lane 7), with an
increase in the amount of the 156-nt RT-PCR product,
although the lariat-derived product remained the major signal
detected by RT-PCR (Fig. 6B, lane 14).
The putative restoration of - pairing with the C452-
G1884 combination was not accompanied by a recovery of the
splicing efficiency of the intron, which remained at 29% of wild-
type values (Fig. 6A, lane 8) or even lower (6%wild-type, lane 9)
in the EBS3CC-G combined mutant. Thus, the G452
residue appears to be required forwild-type splicing activity. As
observed with the C and G mutations, RT-PCR assays for
the C-G mutant indicated no increase in the production of
the 156-nt product (Fig. 6B, lane 16) but, as expected, the RT-
PCR assay (lane 18) showed the levels of intron species with
linked 5 and 3 extremities be higher after the introduction of
the EBS3C mutation.
Evidence of Intron Species with a 2–5 Phosphodiester Bond
between Last and First Residue of Intron—It has been reported
(16, 32, 33) that, in the products amplified from the lariat
intron, adenosine is incorporated instead of thymidine when
the reverse transcriptase encounters the branched adenosine
nucleotide, indicative of a 2-5 junction. Similarly, a branched
G nucleotide causes reverse transcriptase to incorporate a
guanosine residue in place of a cytosine residue (34). As our
results showed that the G mutation allows the splicing and
production of intron species with linked 5 and 3 extremities,
we investigated the nature of the junction by sequencing the
cloned RT-PCR products. Three of the 38 clones from the G
mutant analyzed were indeed derived from these intron forms,
whereas the remaining clones corresponded to lariat forms.
FIGURE 6. Effect of - mutations on the splicing reaction in vivo. A, total RNA from the S. meliloti RMO17 strain harboring the wild-type intron
(pICGterORF/pKGIEP), the splicing-defectivemutantdVand the correspondingmutants,was reverse-transcribedwith an intron-specific primer (P). The cDNA
products obtained from excised intron RNA (97 nt) and unspliced precursor derived transcripts (110 and 126 nt) are indicated, together with the more slowly
migrating bands corresponding to a characteristic pattern of primary precursor transcripts (1041, 1051, and 1070 nt). Splicing efficiency is plotted as a
percentage ofwild-type values, with error bars indicating S.D. B, RmInt1-derived productswere identified by RT-PCR. PCRwas carried outwith () andwithout
() prior RT of RNA from S. meliloti RMO17 harboring the indicated constructs. Total RNAwas isolated with the RNeasyMini Kit (Qiagen), whichminimizes the
amountofDNApresent in theRNAsamples. The typeofproduct amplified is indicated (156and150bp, respectively). Theproducts of themutantsmarkedwith
an asterisk have an extra cytosine residue at the junction.
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Two had an extra cytosine residue at the site of the junction,
and one was of the expected size but for this last clone, we
observed misincorporation of a guanosine residue in place of
the cytosine residue when the reverse transcriptase encoun-
tered the terminal nucleotide (G) of the intron at the junction.
Similarly, eight of 24 clones from the EBS3CGmutant ana-
lyzedwere derived from intron specieswith linked ends. Six had
the extra cytosine residue at the junction, and two were of the
expected size but, again, for these two clones, we observedmis-
incorporation of a guanosine residue at the terminal nucleotide
(G) of the intron. These results suggest that the intron species
generated with joint ends have a 2–5 phosphodiester linkage,
whichmay correspond to intronRNAcircles. By contrast, how-
ever, in the EBS3CC-G mutant, 11 of 24 cloned RT-PCR
products derived from the 156-nt product had the expected
junction between the last and first residues of the intron, but a
cytosine residue was incorporated by the reverse transcriptase
when it encountered the terminal nucleotide of the intron (G).
The more plausible explanation of these results is that, in the
EBS3CC-Gmutant the predominant RT-PCRproducts of
156 nt were derived from tandem, head-to-tail intron
templates.
DISCUSSION
Wepreviously reported that RmInt1 is excised in vivo both as
an intron lariat and as putative intron circles (16). These con-
clusions were based on RT-PCR data, but it is not possible, on
the basis of these assays alone, to determine whether the tem-
plates correspond to genuinely circular intron forms or, alter-
natively, result from the production of tandem, head-to-tail
intron copies. However, the second of these two possibilities
was considered unlikely because these intron forms were also
generated in the absence of general recombination and by an
intron carrying an IEP mutation that abolishes reverse tran-
scriptase activity and thus mobility. We show here that muta-
tions in the predicted coordination loop of RmInt1 lead to
intron excision behavior different from that observed for nucle-
otide substitutions at the branch site adenosine and that intron
forms with joined 5 and 3 extremities are produced indepen-
dently of the branching reaction. The replacement of EBS3 with
nucleotides preventing the EBS3-IBS3 interaction increases the
abundance of intron products inwhich the first G residue of the
intron is linked to the last C residue. These intron forms are
likely produced as a result of intron circularization with a 2–5
phosphodiester bond at the junction aswell as a consequence of
intron reverse splicing into either DNA sites (stable intron
dimers) or RNA sites (transient intron dimers), generating
head-to-tail intronmolecules, by pairing EBS3 (C) with the first
intron nucleotide (G).
The coordination loop has been identified as a possible
receptor for branch site docking, which is required for trans-
esterification, and it has been suggested that the conforma-
tional state of the intron core is fixed early and persists through-
out the entire splicing process (8). If the coordination loop is the
binding site for the branch point, wewould expectmutations in
this loop to result in a phenotype similar to that for nucleotide
substitutions at the branch site. However, for RmInt1, branch
site substitutions prevent branching, whereas the coordination
loop mutants CL1 and CL2 display moderate to strong effects
on splicing, but branched templates clearly predominate
among splicing products. Thus, we cannot rule out the possi-
bility that the branch site receptormutations have effects on the
structure of the ribozyme leading to the splicing defect
observed in vivo for RmInt1. In addition, intronmolecules with
linked 5 and 3 ends are produced in branch sitemutants in the
absence of lariat formation, suggesting that the generation of
such linked products is independent of the branching reaction.
Nonetheless, mutations affecting either the branch site or the
coordination loop significantly decrease the production of
these intron forms (by a factor of 10). It would therefore seem
that the correct structure and proper folding of the intron is
required for wild-type production of these intron-derived
products.
Branch site substitutions are known to prevent branching
and to lead to the relatively inefficient production of linear
intron molecules in other introns. It has been reported that the
linear group II intron ai5 readily reverses the second step of
splicing with high yield and precision in vitro (35). However, we
have no evidence that RmInt1 generates excised linear intron
molecules in vivo: no linear intron RNA was detected by
5RLM-RACE, primer extension or cRT-PCR. In addition,
none of the RmInt1 branch site and coordination loopmutants
showed retrohoming capability (only barely detectable in the
A764Cmutant that produces some lariat molecules) into DNA
recipient target sites (data not shown). It is highly significant
that the RT-PCR products derived from intron forms with
linked 5 and 3 ends generated by G mutants contained an
abnormality, in that aG residuewas incorporated instead of a C
nucleotide when reverse transcriptase encountered the termi-
nal G residue of the intron at the junction. These findings sug-
gest the presence of a 2-5 junction and may therefore repre-
sent intron circles (14). It therefore seems that these intron
forms with linked ends produced by RmInt1 may result as sug-
gested previously (14) from intron molecules that undergo
cleavage at the 3 splice site rather than the first step of the
branching pathway, by a trans-splicing reaction triggered by 5
exonmolecules generated by the so-called spliced exon reopen-
ing reaction. After release of the 3 exon, the 2-OH of the
terminal cytosine residue attacks the 5 splice site, releasing the
5 exon and an intron circle with a 2–5 phosphodiester bond
at the junction.
Primer extension analysis revealed that the EBS3C, U, and A
mutants had a low splicing efficiency, probably due to blockage
of the second step of splicing. Surprisingly, RT-PCR assays
revealed the presence of templates with linked 5 and 3 intron
extremities in the EBS3Cmutant, whereas the product derived
from the intron lariat is no longer detectable. In addition, RT-
qPCR assays revealed that the EBS3C mutant generated 100
times as many of these intron forms as the wild-type intron.
Furthermore, analysis of the plasmid content of the EBS3C
mutant revealed the presence of dimeric and oligomeric head-
to-tail species. The simplest interpretation of the data is that
these intron forms are derived from intron RNA circles linked
by a 2–5 phosphodiester bond (detected by primer extension)
and head-to-tail intronmolecules (revealed by RT-PCR). These
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findings reveal the extraordinary capability of RmInt1 to spread
into both RNA and DNA target sites.
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 Supplementary Table 1. Oligonucleotides used in this work 
OLIGONUCLEOTIDE 
NAME  SEQUENCE 
 EXPERIMENTAL USE  REFERENCE 
dVI-ΔA  5’-CCTCCGGCCT CTCACCCCTG-3’  Construction of ΔA mutant * This work 
dVI-AC  5’-CCTCCGGCCTCCTCACCCCTG-3’  Construction of AC mutant * This work 
dVI-pU  5’-GTTCTGCGAGTAGGCCGGCTG-3’  Construction of pU mutant * This work 
A330C  5’-ACCGGCGTAGCGGGGGCGTGA-3’  Construction of CL2 mutant * This work 
EBS3C  5’-GACCGGCGTACAGGGGGCGTG-3’  Construction of EBS3C mutant * This work 
SacBbr  5’-GGGAGCTCACGTGCCTCGTTTTCATCGATGAGA-3’  Construction CL1 mutant ** 21 
CL/DN  5’-ATAACGACGCGGGGCTGGAGGGTTCACTTTCGTTC-3’  Construction of CL1 mutant ** This work 
CL/UP  5’-GTGAACCCTCCAGCCCCGCGTCGTTATGAACGTAA-3’  Construction of CL1 mutant ** This work 
pT7R  5’-TCGACCCTATAGTGAGTCGTATTACTCGAG-3’  Construction of CL1 mutant **  This work 
5Q_CAT  5’-TGTACCTATAACCAGACCGTTCAG-3’  Construction of  γ- γ’ mutant ** 22 
γC-rv  5’-TACGGGGCGATCGGCCCCAGTCTCCTGCATC-3’  Construction of  γC mutant ** This work 
γC-fw  5’-GACTGGGGCCGATCGCCCCGTATGAGCGTCGAGG-3’  Construction of  γC mutant ** This work 
γ’G  5’-CACCTAGGCCAGGCGTGAGTAGG-3’  Construction of  γ’G mutant ** This work 
6QR_LACZ  5’-GATGTGCTGCAAGGCGATT-3’  Construction of  γ- γ’ mutant ** 22 
Ect1  5’-CACCTGCTCGGATCTCGTC-3’  Reverse transcription and qPCR 17 
P  5’-TGAAAGCCGATCCCGGAG-3’  Primer extension and PCR lariat/circle detection 23 
LL  5’-GAGGTTCACGCACCGTTCTG-3’  PCR lariat/circle detection 17 
ICI  5’-GGATGACGAAACGGTCCTG-3’  Reverse transcription This work 
Iq3’  5’-CTCCTCCGGCCTACTCACC-3’  qPCR This work 
* The mutants were generated with the Altered Sites II in vitro Mutagenesis pAlter-1 System (Promega) 
** The mutants were constructed by two-step PCR, with the Triple Master™ PCR System (Eppendorf) 
 at ESTACION EXPERIMENTAL ZAIDIN, on April 2, 2013 www.jbc.org Downloaded from 
SUPPLEMENTARY FIGURES  
 
 
Supplementary Figure 1. RT-qPCR specificity determination. The amplification plot 
represents fluorescence as a function of cycle number. Fluorescence was measured at 
the end of the elongation step of each cycle, in six replicates running on the same and on 
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separate plates, providing a measurement of variability within and between runs. The 
amplification refractory mutation system (ARMS) is based on the difference in 
efficiency of PCR primer extension between conditions in which the 3’ end is matched 
and those in which it is mismatched to a template. The specificity of an ARMS test can 
be defined as the difference in Cts (ΔCt) observed on qPCR when the test is performed 
on equal amounts of template. Higher ΔCt values are obtained for more specific, 
discriminatory tests. qPCR was performed with serial dilutions of DNA from two 
different templates: CIR and LAR, corresponding to PCR fragments containing the 
ligation point for the 5´and 3´ends and the lariat branch region, respectively. The 
amplification kinetics of the 1.45 x 107 dilution is shown. (A) Ect1/Iq3’ primer pair: 
Ect1 hybridises with both templates, but Iq3’ is complementary to the last six 
nucleotides of the intron; thus Iq3’ efficiently amplifies the CIR template but not the 
LAR template. (B) P/LL primer pair: both oligonucleotides hybridise with the CIR and 
LAR templates. The two primer pairs are similarly efficient when CIR molecules are 
used as a template. (qPCR parameters: E > 95% and R2 > 0.990) 
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 Supplementary Fig. 2. Presence of DNA templates with linked intron 5´and 3´ends in 
RNA preparations. (A) Quantification in samples for constructs containing WT, domain 
V, EBS3C and representative mutants of the coordination loop and branch-site regions. 
The graph shows the threshold cycle (Ct) for the indicated constructs. Values are 
represented as means ± standard errors of three replicates from the same plate. qPCR 
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data for RNA samples not treated with reverse transcriptase were compared with the 
results obtained for cDNA samples. RT- samples showed amplification profiles closer 
to the final PCR cycles. A Ct value of 40 indicates a negative reaction, so the ΔA RT- 
level could not be shown on the graph. Most of the constructs displayed at least a 30-
fold difference between RT- and RT+ amplification levels. Smaller differences were 
found for the EBS3C mutant, indicating the presence of DNA templates in which the 
5´and 3´extremities are linked in RNA preparations. (qPCR parameters: E = 80.7% and 
R2 = 0.994) (B) The migration pattern of products from the above RT-qPCR is shown, 
for correlation of the level of fluorescence with the appearance of amplicons. No band is 
observed in samples not treated with reverse transcriptase, other than the EBS3C 
mutant, for which a 207 bp band is visible. This same band is detected in RT+ lanes for 
WT intron RNA and CL2 and EBS3C mutants. No band appears in the dV or ΔA RT+ 
lanes. 
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